Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	RNA-DNA hybrid ribonuclease activity	NYNRIN ERVK-8 ERVK-7 ERVK-10	8.53e-08	11	82	4	GO:0004523
GeneOntologyMolecularFunction	aspartic-type endopeptidase activity	ERVK-8 ERVK-19 ERVK-7 ERVK-25 ERVK-10	4.06e-07	37	82	5	GO:0004190
GeneOntologyMolecularFunction	aspartic-type peptidase activity	ERVK-8 ERVK-19 ERVK-7 ERVK-25 ERVK-10	4.66e-07	38	82	5	GO:0070001
GeneOntologyMolecularFunction	RNA endonuclease activity, producing 5'-phosphomonoesters	NYNRIN ERVK-8 ERVK-7 ERVK-10	1.57e-05	37	82	4	GO:0016891
GeneOntologyMolecularFunction	RNA-directed DNA polymerase activity	ERVK-8 ERVK-7 ERVK-10	2.35e-05	14	82	3	GO:0003964
GeneOntologyMolecularFunction	endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters	NYNRIN ERVK-8 ERVK-7 ERVK-10	3.78e-05	46	82	4	GO:0016893
GeneOntologyMolecularFunction	RNA stem-loop binding	ERVK-8 ERVK-7 ERVK-10	8.42e-05	21	82	3	GO:0035613
GeneOntologyMolecularFunction	cell adhesion molecule binding	PDXDC1 ROBO4 NEO1 CNTN5 DAB2 CC2D1A RPSA BZW1 GFRA1 CNTN6	1.68e-04	599	82	10	GO:0050839
GeneOntologyMolecularFunction	RNA nuclease activity	NYNRIN ERVK-8 POLRMT ERVK-7 ERVK-10	2.44e-04	136	82	5	GO:0004540
GeneOntologyMolecularFunction	acetylesterase activity	LIPC CEL	2.47e-04	6	82	2	GO:0008126
GeneOntologyMolecularFunction	cell adhesion mediator activity	ROBO4 CNTN5 RPSA CNTN6	2.71e-04	76	82	4	GO:0098631
GeneOntologyMolecularFunction	RNA endonuclease activity	NYNRIN ERVK-8 ERVK-7 ERVK-10	3.14e-04	79	82	4	GO:0004521
GeneOntologyMolecularFunction	D-glucose:sodium symporter activity	SLC5A1 SLC5A4	3.45e-04	7	82	2	GO:0005412
GeneOntologyMolecularFunction	short-chain carboxylesterase activity	LIPC CEL	3.45e-04	7	82	2	GO:0034338
GeneOntologyMolecularFunction	DNA polymerase activity	ERVK-8 ERVK-7 ERVK-10	5.08e-04	38	82	3	GO:0034061
GeneOntologyMolecularFunction	myosin II binding	LLGL2 STXBP5	1.26e-03	13	82	2	GO:0045159
GeneOntologyMolecularFunction	endopeptidase activity	MMP28 FURIN ERVK-8 ERVK-19 ERVK-7 ERVK-25 ERVK-10	1.94e-03	430	82	7	GO:0004175
GeneOntologyMolecularFunction	cell-cell adhesion mediator activity	ROBO4 CNTN5 CNTN6	2.02e-03	61	82	3	GO:0098632
GeneOntologyMolecularFunction	carbohydrate:monoatomic cation symporter activity	SLC5A1 SLC5A4	2.18e-03	17	82	2	GO:0005402
GeneOntologyMolecularFunction	endonuclease activity	NYNRIN ERVK-8 ERVK-7 ERVK-10	2.39e-03	136	82	4	GO:0004519
GeneOntologyMolecularFunction	nuclease activity	NYNRIN ERVK-8 POLRMT ERVK-7 ERVK-10	2.63e-03	231	82	5	GO:0004518
GeneOntologyBiologicalProcess	DNA integration	NYNRIN ERVK-8 ERVK-7 ERVK-10	1.61e-07	13	82	4	GO:0015074
GeneOntologyBiologicalProcess	DNA synthesis involved in DNA repair	NYNRIN ERVK-8 ERVK-7 ERVK-10	3.95e-05	48	82	4	GO:0000731
GeneOntologyBiologicalProcess	dendrite self-avoidance	ROBO4 CNTN5 CNTN6	4.73e-05	18	82	3	GO:0070593
GeneOntologyBiologicalProcess	viral process	SP1 MAVS FURIN ERVK-8 ERVK-19 RPSA ERVK-7 ERVK-10 DDX5	9.35e-05	464	82	9	GO:0016032
Domain	IGc2	IGSF10 ROBO4 HSPG2 NEO1 CNTN5 OBSL1 MUSK CNTN6 IGSF3	4.64e-07	235	76	9	SM00408
Domain	Ig_sub2	IGSF10 ROBO4 HSPG2 NEO1 CNTN5 OBSL1 MUSK CNTN6 IGSF3	4.64e-07	235	76	9	IPR003598
Domain	Ig_I-set	IGSF10 ROBO4 HSPG2 NEO1 CNTN5 OBSL1 MUSK CNTN6	1.03e-06	190	76	8	IPR013098
Domain	I-set	IGSF10 ROBO4 HSPG2 NEO1 CNTN5 OBSL1 MUSK CNTN6	1.03e-06	190	76	8	PF07679
Domain	IG	IGSF10 ROBO4 HSPG2 NEO1 CNTN5 NCAN OBSL1 MUSK CNTN6 IGSF3	7.71e-06	421	76	10	SM00409
Domain	Ig_sub	IGSF10 ROBO4 HSPG2 NEO1 CNTN5 NCAN OBSL1 MUSK CNTN6 IGSF3	7.71e-06	421	76	10	IPR003599
Domain	-	IGSF10 ROBO4 HSPG2 NEO1 CNTN5 NCAN OBSL1 USH2A PKHD1L1 MUSK CNTN6 IGSF3	1.40e-05	663	76	12	2.60.40.10
Domain	Ig-like_fold	IGSF10 ROBO4 HSPG2 NEO1 CNTN5 NCAN OBSL1 USH2A PKHD1L1 MUSK CNTN6 IGSF3	2.61e-05	706	76	12	IPR013783
Domain	IG_LIKE	IGSF10 ROBO4 HSPG2 NEO1 CNTN5 NCAN OBSL1 MUSK CNTN6 IGSF3	2.90e-05	491	76	10	PS50835
Domain	Ig-like_dom	IGSF10 ROBO4 HSPG2 NEO1 CNTN5 NCAN OBSL1 MUSK CNTN6 IGSF3	3.56e-05	503	76	10	IPR007110
Domain	fn3	ROBO4 NEO1 CNTN5 OBSL1 USH2A CNTN6	5.14e-05	162	76	6	PF00041
Domain	LLGL	LLGL2 STXBP5	9.75e-05	4	76	2	PF08366
Domain	Lethal2_giant	LLGL2 STXBP5	9.75e-05	4	76	2	IPR000664
Domain	LLGL2	LLGL2 STXBP5	9.75e-05	4	76	2	IPR013577
Domain	FN3	ROBO4 NEO1 CNTN5 OBSL1 USH2A CNTN6	1.07e-04	185	76	6	SM00060
Domain	FN3	ROBO4 NEO1 CNTN5 OBSL1 USH2A CNTN6	1.60e-04	199	76	6	PS50853
Domain	FN3_dom	ROBO4 NEO1 CNTN5 OBSL1 USH2A CNTN6	2.08e-04	209	76	6	IPR003961
Domain	EGF_LAM_2	HSPG2 LAMB4 USH2A	2.43e-04	30	76	3	PS50027
Domain	EGF_LAM_1	HSPG2 LAMB4 USH2A	2.43e-04	30	76	3	PS01248
Domain	Laminin_EGF	HSPG2 LAMB4 USH2A	3.86e-04	35	76	3	PF00053
Domain	EGF_Lam	HSPG2 LAMB4 USH2A	3.86e-04	35	76	3	SM00180
Domain	Na/solute_symporter_CS	SLC5A1 SLC5A4	4.50e-04	8	76	2	IPR018212
Domain	LAM_G_DOMAIN	HSPG2 FAT3 USH2A	4.93e-04	38	76	3	PS50025
Domain	Laminin_EGF	HSPG2 LAMB4 USH2A	4.93e-04	38	76	3	IPR002049
Domain	Laminin_G_2	HSPG2 FAT3 USH2A	5.74e-04	40	76	3	PF02210
Domain	EGF_1	HSPG2 LAMB4 FAT3 NCAN EPGN USH2A	6.01e-04	255	76	6	PS00022
Domain	LamG	HSPG2 FAT3 USH2A	7.61e-04	44	76	3	SM00282
Domain	NA_SOLUT_SYMP_1	SLC5A1 SLC5A4	8.78e-04	11	76	2	PS00456
Domain	NA_SOLUT_SYMP_2	SLC5A1 SLC5A4	1.05e-03	12	76	2	PS00457
Domain	SSF	SLC5A1 SLC5A4	1.05e-03	12	76	2	PF00474
Domain	Na/solute_symporter	SLC5A1 SLC5A4	1.05e-03	12	76	2	IPR001734
Domain	NA_SOLUT_SYMP_3	SLC5A1 SLC5A4	1.05e-03	12	76	2	PS50283
Domain	Laminin_G	HSPG2 FAT3 USH2A	1.70e-03	58	76	3	IPR001791
Domain	Laminin_N	LAMB4 USH2A	1.89e-03	16	76	2	IPR008211
Domain	LAMININ_NTER	LAMB4 USH2A	1.89e-03	16	76	2	PS51117
Domain	Laminin_N	LAMB4 USH2A	1.89e-03	16	76	2	PF00055
Domain	LamNT	LAMB4 USH2A	1.89e-03	16	76	2	SM00136
Domain	Ig_2	HSPG2 NEO1 CNTN5	3.28e-03	73	76	3	PF13895
Domain	IGv	IGSF10 HSPG2 IGSF3	3.54e-03	75	76	3	SM00406
Domain	EGF-like_CS	HSPG2 LAMB4 FAT3 NCAN EPGN	4.23e-03	261	76	5	IPR013032
Domain	EGF_2	HSPG2 LAMB4 FAT3 NCAN EPGN	4.51e-03	265	76	5	PS01186
Domain	PID	DAB2 ANKS1B	5.77e-03	28	76	2	PF00640
Domain	-	HSPG2 FAT3 USH2A	6.85e-03	95	76	3	2.60.120.200
Domain	PID	DAB2 ANKS1B	7.49e-03	32	76	2	PS01179
Pubmed	A revised nomenclature for transcribed human endogenous retroviral loci.	ERVK-8 ERVK-19 ERVK-7 ERVK-25 ERVK-10	3.38e-06	94	84	5	21542922
Pubmed	Transcription factor SP1 mediates hyperglycemia-induced upregulation of roundabout4 in retinal microvascular endothelial cells.	ROBO4 SP1	5.76e-06	2	84	2	28341181
Pubmed	microRNA-29b mediates fibrotic induction of human xylosyltransferase-I in human dermal fibroblasts via the Sp1 pathway.	XYLT1 SP1	5.76e-06	2	84	2	30542210
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 LLGL2 MDN1 FURIN POLRMT DIP2C CC2D1A RPSA TNRC6C PRAG1 KIAA2013 IGSF3	1.37e-05	1105	84	12	35748872
Pubmed	Furin Functions as a Nonproteolytic Chaperone for Matrix Metalloproteinase-28: MMP-28 Propeptide Sequence Requirement.	MMP28 FURIN	1.73e-05	3	84	2	21152186
Pubmed	Induced lipase mutations in the mouse.	LIPC CEL	1.73e-05	3	84	2	9918035
Pubmed	Differential regulation of mouse kidney sodium-dependent transporters mRNA by cadmium.	SLC5A1 SLC5A4	1.73e-05	3	84	2	11749115
Pubmed	Cleavage activates dispatched for Sonic Hedgehog ligand release.	FURIN DISP1	1.73e-05	3	84	2	29359685
Pubmed	Post-oral appetite stimulation by sugars and nonmetabolizable sugar analogs.	SLC5A1 SLC5A4	1.73e-05	3	84	2	23926132
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	PDXDC1 MYBBP1A NEO1 MAVS PPFIA1 FURIN CC2D1A RPGR PKHD1L1 IGSF3	1.82e-05	777	84	10	35844135
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	MYBBP1A MDN1 FAM186A FAT3 PPFIA1 DDX5	2.28e-05	234	84	6	36243803
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	SP1 MYBBP1A MAVS DAB2 BOP1 CC2D1A PPHLN1 BZW1	3.02e-05	503	84	8	16964243
Pubmed	ANKS1B Gene Product AIDA-1 Controls Hippocampal Synaptic Transmission by Regulating GluN2B Subunit Localization.	ANKS1B KIF17	3.45e-05	4	84	2	26085624
Pubmed	Glycosylphosphatidylinositol anchored recognition molecules that function in axonal fasciculation, growth and guidance in the nervous system.	CNTN5 CNTN6	3.45e-05	4	84	2	1838307
Pubmed	Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans.	ERVK-7 ERVK-10	3.45e-05	4	84	2	10469592
Pubmed	MMP28 gene expression is regulated by Sp1 transcription factor acetylation.	SP1 MMP28	3.45e-05	4	84	2	20144149
Pubmed	Human endogenous retrovirus K10: expression of Gag protein and detection of antibodies in patients with seminomas.	ERVK-19 ERVK-10	3.45e-05	4	84	2	7983737
Pubmed	Expression and prognostic significance of MAGE-A11 and transcription factors (SP1,TFCP2 and ZEB1) in ESCC tissues.	SP1 MAGEA11	3.45e-05	4	84	2	31126819
Pubmed	Expression of the immunoglobulin superfamily cell adhesion molecules in the developing spinal cord and dorsal root ganglion.	IGSF10 CNTN5 OBSL1 CNTN6 IGSF3	4.73e-05	162	84	5	25826454
Pubmed	The Crystal Structure of the Ubiquitin-like Domain of Ribosome Assembly Factor Ytm1 and Characterization of Its Interaction with the AAA-ATPase Midasin.	MDN1 BOP1	5.74e-05	5	84	2	26601951
Pubmed	Quantitation of HERV-K env gene expression and splicing in human breast cancer.	ERVK-19 ERVK-7	5.74e-05	5	84	2	12629516
Pubmed	Structural Basis for Interactions Between Contactin Family Members and Protein-tyrosine Phosphatase Receptor Type G in Neural Tissues.	CNTN5 CNTN6	5.74e-05	5	84	2	27539848
Pubmed	DDX5 (p68) orchestrates β-catenin, RelA and SP1 mediated MGMT gene expression in human colon cancer cells: Implication in TMZ chemoresistance.	SP1 DDX5	5.74e-05	5	84	2	37793472
Pubmed	A hypomorphic IgH-chain allele affects development of B-cell subsets and favours receptor editing.	SIGLEC16 PLCG2	5.74e-05	5	84	2	21623346
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KLHL29 STXBP5 OBSL1 TNRC6C CAMSAP2 KIF17 EPG5	5.96e-05	407	84	7	12693553
Pubmed	Xylosyltransferase-1 expression is refractory to inhibition by the inflammatory cytokines tumor necrosis factor α and IL-1β in nucleus pulposus cells: novel regulation by AP-1, Sp1, and Sp3.	XYLT1 SP1	8.59e-05	6	84	2	25476526
Pubmed	Etv1 Controls the Establishment of Non-overlapping Motor Innervation of Neighboring Facial Muscles during Development.	SPON1 SORCS3 FIGN	1.08e-04	38	84	3	31597102
Pubmed	Whirlin replacement restores the formation of the USH2 protein complex in whirlin knockout photoreceptors.	RPGR USH2A	1.20e-04	7	84	2	21212183
Pubmed	Advances in the understanding of skeletal muscle weakness in murine models of diseases affecting nerve-evoked muscle activity, motor neurons, synapses and myofibers.	HSPG2 MUSK	1.20e-04	7	84	2	25042397
Pubmed	A protein interaction network for pluripotency of embryonic stem cells.	SP1 MYBBP1A SALL4	1.36e-04	41	84	3	17093407
Pubmed	Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.	MYBBP1A POLRMT RPSA LARP4 DDX5	2.12e-04	223	84	5	20020773
Pubmed	Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations.	PDXDC1 LIPC PCDH20	2.17e-04	48	84	3	22359512
Pubmed	Novel role for Netrins in regulating epithelial behavior during lung branching morphogenesis.	HSPG2 NEO1	3.13e-04	11	84	2	15186747
Pubmed	Quantitative proteomics identifies the Myb-binding protein p160 as a novel target of the von Hippel-Lindau tumor suppressor.	MYBBP1A BOP1	3.13e-04	11	84	2	21386990
Pubmed	A role for Nr-CAM in the patterning of binocular visual pathways.	CNTN5 CNTN6	3.75e-04	12	84	2	16701205
Pubmed	Genomewide screening for fusogenic human endogenous retrovirus envelopes identifies syncytin 2, a gene conserved on primate evolution.	ERVK-8 ERVK-19	3.75e-04	12	84	2	14557543
Pubmed	Single-nucleus RNA sequencing of developing superior colliculus identifies neuronal diversity and candidate mediators of circuit assembly.	SPON1 GFRA1	4.42e-04	13	84	2	37624694
Pubmed	Pioneering axons regulate neuronal polarization in the developing cerebral cortex.	CNTN5 CNTN6	4.42e-04	13	84	2	24559674
Pubmed	Defining the membrane proteome of NK cells.	MYBBP1A MDN1 ALDH16A1 FURIN CC2D1A RPSA BZW1 LARP4 KIAA2013 DDX5	5.10e-04	1168	84	10	19946888
Pubmed	Identification of genes differentially expressed in B16 murine melanoma sublines with different metastatic potentials.	RPSA DDX5	5.15e-04	14	84	2	8631027
Pubmed	Chromosomal localization of lipolytic enzymes in the mouse: pancreatic lipase, colipase, hormone-sensitive lipase, hepatic lipase, and carboxyl ester lipase.	LIPC CEL	5.15e-04	14	84	2	8105016
Pubmed	Comprehensive copy number variant (CNV) analysis of neuronal pathways genes in psychiatric disorders identifies rare variants within patients.	CNTN5 GRM8 CNTN6	5.82e-04	67	84	3	20398908
Pubmed	Extensive proteomic screening identifies the obesity-related NYGGF4 protein as a novel LRP1-interactor, showing reduced expression in early Alzheimer's disease.	ANKS1B CC2D1A	5.93e-04	15	84	2	20205790
Pubmed	Interaction between the scaffold proteins CBP by IQGAP1 provides an interface between gene expression and cytoskeletal activity.	ANKS1B CAMSAP2 EPG5	6.35e-04	69	84	3	32238831
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	HSPG2 NYNRIN PPFIA1 DAB2 HSFX1 CAMSAP2 KIF17	6.83e-04	608	84	7	16713569
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	MYBBP1A POLRMT PPHLN1 RPSA BZW1 LARP4 PCDH20 DDX5	7.49e-04	807	84	8	22681889
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	PDXDC1 MYBBP1A LLGL2 MDN1 BZW1 DISP1 DDX5 EPG5	7.49e-04	807	84	8	30575818
Pubmed	Expression patterns of transcribed human endogenous retrovirus HERV-K(HML-2) loci in human tissues and the need for a HERV Transcriptome Project.	ERVK-25 ERVK-10	8.60e-04	18	84	2	18664271
Pubmed	Development of a diagnostic genetic test for simplex and autosomal recessive retinitis pigmentosa.	RPGR USH2A	8.60e-04	18	84	2	20591486
Pubmed	Genetic differences between the determinants of lipid profile phenotypes in African and European Americans: the Jackson Heart Study.	LIPC NCAN	9.60e-04	19	84	2	19148283
Pubmed	A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation.	ZNF711 CFAP47	1.06e-03	20	84	2	19377476
Pubmed	Sall4 isoforms act during proximal-distal and anterior-posterior axis formation in the mouse embryo.	FURIN SALL4	1.17e-03	21	84	2	18781635
Pubmed	USP7 represses lineage differentiation genes in mouse embryonic stem cells by both catalytic and noncatalytic activities.	ZNF711 MAGEA11 ANKRD33 MAVS NYNRIN RPGR GFRA1	1.24e-03	674	84	7	37196079
Pubmed	The necdin interactome: evaluating the effects of amino acid substitutions and cell stress using proximity-dependent biotinylation (BioID) and mass spectrometry.	MYBBP1A BOP1 CC2D1A RPSA DDX5	1.25e-03	330	84	5	32529326
Pubmed	Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking.	SP1 MDN1 DAB2 BZW1 DDX5	1.28e-03	332	84	5	32786267
Pubmed	Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.	ANKRD33 ANKS1B	1.29e-03	22	84	2	21107309
Pubmed	Time-sequenced transcriptomes of developing distal mouse limb buds: A comparative tissue layer analysis.	LLGL2 SALL4	1.29e-03	22	84	2	34254395
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	MYBBP1A OBSL1 BOP1 PPHLN1 LARP4 DISP1	1.30e-03	496	84	6	31343991
Pubmed	Cdh1-APC Regulates Protein Synthesis and Stress Granules in Neurons through an FMRP-Dependent Mechanism.	MYBBP1A RPSA LARP4 DDX5	1.35e-03	197	84	4	32434143
Pubmed	The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment.	SP1 DDX5	1.41e-03	23	84	2	37319434
Pubmed	A dual-strategy expression screen for candidate connectivity labels in the developing thalamus.	FAT3 GFRA1 CNTN6	1.42e-03	91	84	3	28558017
Pubmed	Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients.	CNTN5 DIP2C EPGN	1.42e-03	91	84	3	22610502
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	ZNF711 HSPG2 MYBBP1A BOP1 LARP4	1.60e-03	349	84	5	25665578
Pubmed	Directed proteomic analysis of the human nucleolus.	MYBBP1A BOP1 RPSA DDX5	1.65e-03	208	84	4	11790298
Pubmed	Genes and microRNAs associated with mouse cleft palate: A systematic review and bioinformatics analysis.	FIGN DISP1	1.67e-03	25	84	2	29475039
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	MYBBP1A POLRMT BOP1 PPHLN1 RPSA LARP4 DDX5	1.71e-03	713	84	7	29802200
Pubmed	Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.	ALDH16A1 PPFIA1 DAB2 CC2D1A RPGR LARP4 DDX5 EPG5	1.78e-03	925	84	8	28986522
Pubmed	Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation.	PPHLN1 RPSA PRAG1 CAMSAP2 DDX5	1.85e-03	361	84	5	30344098
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	KLHL29 PPFIA1 OBSL1 TNRC6C LARP4	1.92e-03	364	84	5	24778252
Pubmed	Creation of genome-wide protein expression libraries using random activation of gene expression.	CFAP47 LAMB4 FAM186A GRM8 PKHD1L1	1.99e-03	367	84	5	11329013
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	NEO1 MAVS ICE2 PPFIA1 PPHLN1 BZW1 LARP4	2.00e-03	733	84	7	34672954
Pubmed	TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1.	MYBBP1A LLGL2 DAB2 OBSL1 BOP1 RPSA LARP4 DDX5	2.09e-03	949	84	8	36574265
Pubmed	Proteomics analysis of nucleolar SUMO-1 target proteins upon proteasome inhibition.	MYBBP1A DDX5	2.09e-03	28	84	2	19596686
Pubmed	The E3 ubiquitin ligase Siah1 regulates adrenal gland organization and aldosterone secretion.	PIK3C2G DAB2	2.09e-03	28	84	2	29212953
Pubmed	Interaction between DMRT1 function and genetic background modulates signaling and pluripotency to control tumor susceptibility in the fetal germ line.	SALL4 GFRA1	2.09e-03	28	84	2	23473982
Pubmed	DNMT3L promotes quiescence in postnatal spermatogonial progenitor cells.	SALL4 GFRA1	2.09e-03	28	84	2	24850856
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	SPON1 OBSL1 DIP2C TNRC6C	2.20e-03	225	84	4	12168954
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	PDXDC1 STXBP5 PPFIA1 DAB2 IGSF3	2.23e-03	377	84	5	38117590
Pubmed	Osteoblast-specific expression of Panx3 is dispensable for postnatal bone remodeling.	LIPC SPON1 FAT3	2.31e-03	108	84	3	31202927
Pubmed	Germline deletion of Cdyl causes teratozoospermia and progressive infertility in male mice.	SALL4 GFRA1	2.40e-03	30	84	2	30850578
Cytoband	11q22.1	CNTN5 ERVK-25	2.90e-04	14	83	2	11q22.1
Cytoband	15q22.2	ICE2 LDHAL6B	1.27e-03	29	83	2	15q22.2
Cytoband	22q12.3	SLC5A1 SLC5A4	1.64e-03	33	83	2	22q12.3
Cytoband	Xp21.1	CFAP47 RPGR	1.74e-03	34	83	2	Xp21.1
Cytoband	12q13.12	FAM186A LARP4	2.18e-03	38	83	2	12q13.12
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	IGSF10 ROBO4 HSPG2 NEO1 CNTN5 OBSL1 SIGLEC16 MUSK CNTN6	5.16e-10	161	50	9	593
GeneFamily	Immunoglobulin like domain containing	HSPG2 NEO1 CNTN5 OBSL1 MUSK IGSF3	1.47e-05	193	50	6	594
GeneFamily	Fibronectin type III domain containing	ROBO4 NEO1 CNTN5 USH2A CNTN6	7.83e-05	160	50	5	555
GeneFamily	Lipases\|Arylacetamide deacetylase family	LIPC CEL	1.67e-03	22	50	2	464
ToppCell	COVID-19_Severe-HSPC\|World / disease group, cell group and cell class	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4 FIGN	1.69e-09	189	79	8	555c0b13f1508b9e3712b36d77144e73e828bc76
ToppCell	COVID-19_Severe-HSPC\|COVID-19_Severe / disease group, cell group and cell class	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4 FIGN	1.69e-09	189	79	8	96015439971e2e5b8d6294ca5a6b873c7774e925
ToppCell	facs-Diaphragm-Limb_Muscle-24m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2G FAT3 SORCS3 RNF17 USH2A PKHD1L1 CNTN6	2.15e-08	169	79	7	12bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCell	mild_COVID-19-HSPC\|World / disease group, cell group and cell class (v2)	ZNF711 ROBO4 HSPG2 OBSL1 PGAP4 FIGN VN1R1	2.24e-08	170	79	7	85c476e0bc496445e868a88849960598d97bdea2
ToppCell	PBMC-Mild-Hematopoietic-HSPC-HSPC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	3.19e-08	179	79	7	4bb2debfc9e9f258cd38e797ef160bd440aad6af
ToppCell	PBMC-Mild-Hematopoietic-HSPC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	3.19e-08	179	79	7	2f690f933bf6b99abeb31766e0b22bdbe36c1ba0
ToppCell	PBMC-Mild-Hematopoietic-HSPC-HSPC\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	3.19e-08	179	79	7	3e2c937369b8190fd5d5a31689d029e6e89fb5e2
ToppCell	PBMC-Mild-Hematopoietic-HSPC-HSPC-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	3.45e-08	181	79	7	e7f7b519c2a01c15f26df11ec9b434c0d1630c7a
ToppCell	PBMC-Mild-Hematopoietic-HSPC-HSPC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	3.45e-08	181	79	7	54a19cf6a3b752e2391feb8b316bebee0e602d17
ToppCell	PBMC-Mild-Hematopoietic-HSPC\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	3.45e-08	181	79	7	5b84625b1d3737708001b64f6da9360330d39a27
ToppCell	COVID-19_Severe-Hematopoietic_SC-HSPC\|COVID-19_Severe / Disease group, lineage and cell class	IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4 FIGN	3.72e-08	183	79	7	4146b1c0e5f76d25226745abfa28f77127a444fc
ToppCell	COVID-19_Severe-Hematopoietic_SC\|COVID-19_Severe / Disease group, lineage and cell class	IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4 FIGN	3.72e-08	183	79	7	92aab7ce65aca17988bc2add4ff9fb8384e2c21b
ToppCell	PBMC-Severe-Hematopoietic-HSPC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	3.86e-08	184	79	7	a6169613c6493b947a176493f542368bfa935dab
ToppCell	PBMC-Severe-Hematopoietic-HSPC-HSPC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	3.86e-08	184	79	7	51d0447699e3b8f01abbde83f26b748bc9f3c723
ToppCell	PBMC-Severe-Hematopoietic-HSPC-HSPC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	3.86e-08	184	79	7	f7b0bb45a9055ab34e98b251217f6ec38c75ca22
ToppCell	PBMC-Severe-Hematopoietic-HSPC-HSPC\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	3.86e-08	184	79	7	cc01c19180861f491a8dc16d60fabd1215fc4525
ToppCell	PBMC-Severe-Hematopoietic-HSPC-HSPC-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	3.86e-08	184	79	7	492c680f0769ba4e651d09c2e8e5d5d271ed08aa
ToppCell	PBMC-Severe-Hematopoietic-HSPC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	3.86e-08	184	79	7	26edbf84216538b80f1ffcc079ee6e385a71fbf9
ToppCell	COVID-19-COVID-19_Severe-Others-HSPC\|COVID-19_Severe / Disease, condition lineage and cell class	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 FIGN	6.60e-08	199	79	7	25de67b6c9c8d6bb9a538e071a40ef865906c95d
ToppCell	Healthy_donor-HSPC\|World / disease group, cell group and cell class (v2)	ZNF711 IGSF10 HSPG2 NYNRIN OBSL1 PGAP4	5.31e-07	167	79	6	70630ebdfee8171d625811844f8a7c94736d101e
ToppCell	COVID-19-Heart-Neuronal\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KLHL29 DIP2C SORCS3 RPGR FIGN GFRA1	5.50e-07	168	79	6	88c2c574f428c2502b5fe099bd73b0758f668ef6
ToppCell	mild_COVID-19-HSPC\|mild_COVID-19 / disease group, cell group and cell class (v2)	ZNF711 ROBO4 HSPG2 OBSL1 PGAP4 FIGN	5.50e-07	168	79	6	90b33962adb77d8326dee403712118398b4d1315
ToppCell	severe_COVID-19-HSPC\|severe_COVID-19 / disease group, cell group and cell class (v2)	ROBO4 HSPG2 NYNRIN OBSL1 PGAP4 FIGN	6.75e-07	174	79	6	6d35bacf073537b272ff821e604c899fb9ce6a7c
ToppCell	severe_COVID-19-HSPC\|World / disease group, cell group and cell class (v2)	ROBO4 HSPG2 NYNRIN OBSL1 PGAP4 FIGN	7.46e-07	177	79	6	289f6aed6f054b04b01659434d8c8b467d1bf5dd
ToppCell	COVID-19_Mild-Hematopoietic_SC-HSPC\|COVID-19_Mild / Disease group, lineage and cell class	IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	7.97e-07	179	79	6	19fcf48f5e02e4cb2b328efb4502f337e1282f72
ToppCell	severe-Others-CD34+_GATA2+_cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ZNF711 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	7.97e-07	179	79	6	dd789a1b7327d6f9ed5272f3eb54bd43f7ae8d78
ToppCell	COVID-19_Mild-Hematopoietic_SC\|COVID-19_Mild / Disease group, lineage and cell class	IGSF10 ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	7.97e-07	179	79	6	50a073166e34bcfa52a62c4dafb3aef724e0fa8e
ToppCell	PBMC-Control-Hematopoietic-HSPC-HSPC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ZNF711 IGSF10 HSPG2 NYNRIN OBSL1 PGAP4	8.78e-07	182	79	6	6497eeafb2b137e70261ec0314782831892a940d
ToppCell	PBMC-Control-Hematopoietic-HSPC-HSPC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF711 IGSF10 HSPG2 NYNRIN OBSL1 PGAP4	8.78e-07	182	79	6	d0ebf2f0d5370458ab81485a0017c311077133d5
ToppCell	PBMC-Control-Hematopoietic-HSPC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZNF711 IGSF10 HSPG2 NYNRIN OBSL1 PGAP4	8.78e-07	182	79	6	bd1626261803324084fafca2f6665b50854e7fae
ToppCell	PBMC-Control-Hematopoietic-HSPC-HSPC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF711 IGSF10 HSPG2 NYNRIN OBSL1 PGAP4	8.78e-07	182	79	6	2a6d1246bfb5899a0861c7f2f8fb9b43b0df8acc
ToppCell	PBMC-Control-Hematopoietic-HSPC\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF711 IGSF10 HSPG2 NYNRIN OBSL1 PGAP4	8.78e-07	182	79	6	918286422b3eab32d962b49aa07b1b9512e51d9d
ToppCell	PBMC-Control-Hematopoietic-HSPC-HSPC\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	ZNF711 IGSF10 HSPG2 NYNRIN OBSL1 PGAP4	8.78e-07	182	79	6	0d9b8c900da8cbae9cde72aecd4026b1ac2bbd67
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2G FAT3 SALL4 FIGN USH2A PKHD1L1	9.35e-07	184	79	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2G FAT3 SALL4 FIGN USH2A PKHD1L1	9.35e-07	184	79	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2G FAT3 SALL4 FIGN USH2A PKHD1L1	9.35e-07	184	79	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Healthy-HSPC\|World / disease group, cell group and cell class	ZNF711 IGSF10 HSPG2 NYNRIN OBSL1 PGAP4	1.03e-06	187	79	6	8cd9e5499e5c2b2321ecbcf780df37fe0f165ac9
ToppCell	PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ROBO4 HSPG2 MMP28 FURIN PLCG2 SLC5A4	1.16e-06	191	79	6	e3fc5c92491b6e334abffbf085c00a0b5fa1aed2
ToppCell	Control-Control-Others-HSPC\|Control / Disease, condition lineage and cell class	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1	1.48e-06	199	79	6	b71169be0d916b2ed139a3122d78bb154c71edb4
ToppCell	COVID-19-COVID-19_Mild-Others-HSPC\|COVID-19_Mild / Disease, condition lineage and cell class	ZNF711 IGSF10 ROBO4 HSPG2 NYNRIN OBSL1	1.48e-06	199	79	6	0230103c37ae3aff58240739b89f2c36b1e39a69
ToppCell	COVID-19-Fibroblasts-Mesothelial_FB\|COVID-19 / group, cell type (main and fine annotations)	CNTN5 EPGN GRM8 USH2A PKHD1L1	5.27e-06	141	79	5	7e6dcccb74e7ee90b69dc91b59491b84f3a713c9
ToppCell	COVID_non-vent-Myeloid-Monocytic-SC_&_Eosinophil\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	ZNF711 ROBO4 NYNRIN OBSL1 PGAP4	9.16e-06	158	79	5	0d4fe87fc7901dd5f9c004e91708a03cafdb4ad9
ToppCell	facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FAT3 ANKS1B USH2A PKHD1L1 CNTN6	1.03e-05	162	79	5	bf886e22ff2a20353499004b53f25fb9e6574896
ToppCell	Multiple_Sclerosis-Other-HSPC\|Multiple_Sclerosis / Disease, Lineage and Cell Type	IGSF10 CEL NYNRIN OBSL1 PGAP4	1.10e-05	164	79	5	6af5529507d695b347adee4be5ead70f56c9cf55
ToppCell	Int-URO-Myeloid-tDC\|Int-URO / Disease, Lineage and Cell Type	IGSF10 HSPG2 DAB2 OBSL1 KIF17	1.13e-05	165	79	5	9803c3db6cdcf925bea7d9c382bf4fd05acf3509
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4\|Liver / Manually curated celltypes from each tissue	CEL PIK3C2G MMP28 SORCS3 RPSA	1.20e-05	167	79	5	ab6273ae5d76a3f9a05c58320e3dee80f9b99e47
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)\|368C / Donor, Lineage, Cell class and subclass (all cells)	ROBO4 PIK3C2G RPGR PKHD1L1 IGSF3	1.23e-05	168	79	5	a74c8a9e3299183fba31ce3053ef325b5dbcd104
ToppCell	368C-Endothelial_cells-Endothelial-F_(Lymphatics)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	ROBO4 PIK3C2G RPGR PKHD1L1 IGSF3	1.23e-05	168	79	5	dae37b316ce80dfe4236c4ed7f0d4e7c340fa7b6
ToppCell	Healthy_donor-HSPC\|Healthy_donor / disease group, cell group and cell class (v2)	ZNF711 IGSF10 NYNRIN OBSL1 PGAP4	1.38e-05	172	79	5	bc7549faadfc92c683c0e26bea380458706774b5
ToppCell	mild-Others-CD34+_GATA2+_cells\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ROBO4 HSPG2 NYNRIN OBSL1 PGAP4	1.38e-05	172	79	5	379f6f271e653d5e404851e51a189bd582bb0f43
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2G RPSA RNF17 USH2A PKHD1L1	1.42e-05	173	79	5	66f37c1437705734b20601656fa4aa1d92ca30be
ToppCell	facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2G RPSA RNF17 USH2A PKHD1L1	1.42e-05	173	79	5	649b08a409095592cccf31883be69c754411280d
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL29 LIPC FAT3 CNTN5 FIGN	1.54e-05	176	79	5	327a3e81b724252e36d786de92a3ffd721ea6d7b
ToppCell	control-Others-CD34+_GATA2+_cells\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ZNF711 HSPG2 NYNRIN OBSL1 PGAP4	1.63e-05	178	79	5	2120bd3e099b0b271bf079db9827a2f3eee2f909
ToppCell	droplet-Liver-LIVER_HEP-30m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 ROBO4 HSPG2 NYNRIN ANKS1B	1.72e-05	180	79	5	dd1b10c7f5a0fbc63163844ca1882884a24a84d3
ToppCell	droplet-Liver-LIVER_HEP\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 ROBO4 HSPG2 NYNRIN ANKS1B	1.72e-05	180	79	5	423454e3390080ae03bb3cbb267255ebfe4df080
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD\|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	FAT3 CNTN5 ANKS1B USH2A SLC5A1	1.77e-05	181	79	5	c80ffa2ded5975a88e9a1a7d333196f95237bf0a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL29 LIPC FAT3 CNTN5 FIGN	1.77e-05	181	79	5	071f9bb5d39070cdc473d9b0e094d196bc702b56
ToppCell	Control-Hematopoietic_SC-HSPC\|Control / Disease group, lineage and cell class	IGSF10 HSPG2 NYNRIN OBSL1 PGAP4	1.81e-05	182	79	5	14e347c0e6444410f1948851407bb18c706569f4
ToppCell	Control-Hematopoietic_SC\|Control / Disease group, lineage and cell class	IGSF10 HSPG2 NYNRIN OBSL1 PGAP4	1.81e-05	182	79	5	43243c6bae2ac7fa3fd1f193a17f61ee4d938ea9
ToppCell	healthy_donor-Myeloid-Monocytic-SC_&_Eosinophil\|healthy_donor / Disease condition, Lineage, Cell class and subclass	ZNF711 NYNRIN OBSL1 PGAP4 EPGN	1.81e-05	182	79	5	6bd6c32c48fecd6d03ac8a09e405b3b99bdc12ae
ToppCell	droplet-Liver-Npc-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IGSF10 ROBO4 HSPG2 NYNRIN PGAP4	1.81e-05	182	79	5	b1ec2015aad1181eac1bbf8d48ad6f2f7ed24a01
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL29 LIPC FAT3 CNTN5 FIGN	1.86e-05	183	79	5	738e94b50c4c08c727d4eed0708dda08aa6891b4
ToppCell	droplet-Liver-nan-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 HSPG2 NYNRIN DAB2 FIGN	1.86e-05	183	79	5	709a486154b3157427deb3b8886b63ac39ea42dd
ToppCell	droplet-Liver-nan-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO4 HSPG2 NYNRIN DAB2 FIGN	1.86e-05	183	79	5	dc06f19f6f80f4c7f13f1f990c1fe0f91ba64ea7
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KLHL29 LIPC FAT3 CNTN5 FIGN	1.86e-05	183	79	5	92fbd83a9d13ee91065cbd479fb298f1fd564568
ToppCell	COVID-19_Moderate-HSPC\|World / disease group, cell group and cell class	ZNF711 IGSF10 NYNRIN OBSL1 PGAP4	1.91e-05	184	79	5	ccc93babe1fcdeb66b78e1d8414357877a7c45bd
ToppCell	3'-Child04-06-SmallIntestine-Epithelial-Tuft-related-Tuft\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FURIN OBSL1 CC2D1A PLCG2 CNTN6	1.96e-05	185	79	5	686ed7550c6acd18e71e0076936ec5b07389adbd
ToppCell	COVID-19_Moderate-HSPC\|COVID-19_Moderate / disease group, cell group and cell class	ZNF711 IGSF10 NYNRIN OBSL1 PGAP4	1.96e-05	185	79	5	cacc6ab5f26f6c803894567fb838ea06eaa7efe5
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	LAMB4 FAM186A CNTN5 SORCS3 USH2A	2.01e-05	186	79	5	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	PCW_07-8.5-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	ROBO4 HSPG2 MMP28 PLCG2 SLC5A4	2.07e-05	187	79	5	29b2e2be26a9d72b154760e47acf61cfe2f45fa7
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XYLT1 SPON1 NCAN PCDH20 CNTN6	2.12e-05	188	79	5	7471c194276161422326647f09022e94f3d1640c
ToppCell	PCW_13-14-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ROBO4 HSPG2 MMP28 PLCG2 SLC5A4	2.12e-05	188	79	5	b66f1f08827dd6c48583d871f9f33ea41e48bfb2
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-oligodendrocyte_precursor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XYLT1 SPON1 NCAN SORCS3 CNTN6	2.12e-05	188	79	5	a244fcd092d5bd544e503366b1439b0fbc1ee00e
ToppCell	facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XYLT1 SPON1 NCAN PCDH20 CNTN6	2.12e-05	188	79	5	053c251d3ddbeb866f34565aefca4535517b4387
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-Oligodendrocyte_progenitor_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XYLT1 SPON1 NCAN SORCS3 CNTN6	2.12e-05	188	79	5	c8530c9ff98666c64a94683261af4288cb790a7e
ToppCell	COVID_vent-Myeloid-Monocytic-SC_&_Eosinophil\|COVID_vent / Disease condition, Lineage, Cell class and subclass	ZNF711 ROBO4 NYNRIN OBSL1 PGAP4	2.17e-05	189	79	5	2157a2d40613f7d5ce2e7dbd266df441e449cdaf
ToppCell	systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	ZNF711 IGSF10 NYNRIN OBSL1 PGAP4	2.17e-05	189	79	5	6687a93ac8540ece5fd762f6f77c1f25f159195b
ToppCell	Healthy-HSPC\|Healthy / disease group, cell group and cell class	ZNF711 IGSF10 HSPG2 NYNRIN PGAP4	2.17e-05	189	79	5	214b225effc40ca1b83dd8052f2a7b80b65d4938
ToppCell	10x_3'_v2v3-Non-neoplastic-Endothelial-Endothelial_mature-Endo_arterial-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ROBO4 HSPG2 MMP28 RPGR SLC5A4	2.23e-05	190	79	5	06bfb62b94b0faf467ef93d5bc5d08924c770098
ToppCell	droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	KLHL29 HSPG2 MMP28 NYNRIN PKHD1L1	2.23e-05	190	79	5	3cf464664d6aa22b212e60b70885953887e92483
ToppCell	PCW_10-12-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	ROBO4 HSPG2 MMP28 PLCG2 SLC5A4	2.23e-05	190	79	5	7ba2be2630183df86de21689289a8620a4cd507e
ToppCell	PSB-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KIAA1210 CEL FAT3 PLCG2 GFRA1	2.29e-05	191	79	5	8f4637e801554e2343b974fe7794f01dd2151418
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 SPON1 FAT3 SORCS3 GFRA1	2.29e-05	191	79	5	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	Control-Stromal_mesenchymal\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 SPON1 FAT3 SORCS3 GFRA1	2.29e-05	191	79	5	14057205ddb9b4bbc582d1358d13cf36d979a61b
ToppCell	RA-09._Endothelium_I\|World / Chamber and Cluster_Paper	ROBO4 HSPG2 RPGR PRAG1 PKHD1L1	2.29e-05	191	79	5	c8a0c2af119bc34a8f694a7d30642f28002c84b9
ToppCell	Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SPON1 FAT3 ANKS1B PRAG1 DISP1	2.34e-05	192	79	5	72881b280a415e65f87a80ca1369cbb0b722a0c4
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 SPON1 FAT3 SORCS3 GFRA1	2.34e-05	192	79	5	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	RA-09._Endothelium_I\|RA / Chamber and Cluster_Paper	ROBO4 HSPG2 RPGR PRAG1 PKHD1L1	2.34e-05	192	79	5	8a1b1c3e83a68ad74f8f4eb00455c9e41aa57cfc
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 SPON1 FAT3 SORCS3 GFRA1	2.40e-05	193	79	5	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	15-Airway-Endothelial\|Airway / Age, Tissue, Lineage and Cell class	ROBO4 HSPG2 MMP28 PLCG2 KIF17	2.46e-05	194	79	5	ac0e48b0c09a7f57d30dff321b0c30a4c5e16ad9
ToppCell	15-Airway-Endothelial-Endothelial\|Airway / Age, Tissue, Lineage and Cell class	ROBO4 HSPG2 MMP28 PLCG2 KIF17	2.46e-05	194	79	5	f3851337a2d17f4acef2cd812a766eb0b503748b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 SPON1 FAT3 SORCS3 GFRA1	2.46e-05	194	79	5	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 SPON1 FAT3 SORCS3 GFRA1	2.46e-05	194	79	5	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	COVID-19-kidney-Glomerular_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ROBO4 RPGR PLCG2 PKHD1L1 SLC5A4	2.46e-05	194	79	5	660535b492445063d965095a50e1e299ce04c50a
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	IGSF10 SPON1 FAT3 SORCS3 GFRA1	2.46e-05	194	79	5	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	COVID-19-kidney-PLVAP+EC\|kidney / Disease (COVID-19 only), tissue and cell type	ROBO4 HSPG2 RPGR PLCG2 SLC5A4	2.52e-05	195	79	5	a436483fec137584611f86b7a498a4dc2aa19cd3
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	NEO1 SPON1 FAT3 ANKS1B PRAG1	2.52e-05	195	79	5	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	COVID-19-kidney-Fibroblast-2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KLHL29 XYLT1 SPON1 FIGN GFRA1	2.52e-05	195	79	5	3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2
ToppCell	Tracheal-10x3prime_v2-Stromal-Schwann-Schwann_nonmyelinating\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	XYLT1 MMP28 TNRC6C FIGN KIAA2013	2.78e-05	199	79	5	a92718a3f1153b8d2196fd343ed5bc0ebc98cad7
Disease	level of Phosphatidylcholine (18:1_20:3) in blood serum	PDXDC1 LIPC NCAN	3.53e-07	6	78	3	OBA_2045103
Disease	level of Phosphatidylinositol (18:0_20:3) in blood serum	PDXDC1 LIPC MUSK	3.84e-06	12	78	3	OBA_2045157
Disease	level of Phosphatidylcholine (15:0_18:2) in blood serum	PDXDC1 LIPC MUSK	1.41e-05	18	78	3	OBA_2045065
Disease	level of Phosphatidylcholine (16:0_18:2) in blood serum	PDXDC1 LIPC MUSK	1.96e-05	20	78	3	OBA_2045071
Disease	level of Phosphatidylethanolamine (18:0_18:2) in blood serum	PDXDC1 LIPC MUSK	5.55e-05	28	78	3	OBA_2045139
Disease	choline measurement, phosphatidylcholine measurement	LIPC NCAN	6.86e-05	5	78	2	EFO_0010116, EFO_0010226
Disease	1-palmitoyl-2-dihomo-linolenoyl-GPC (16:0/20:3n3 or 6) measurement	PDXDC1 MUSK	6.86e-05	5	78	2	EFO_0800407
Disease	sphingomyelin measurement	PDXDC1 LIPC NCAN TNRC6C USH2A MUSK	9.64e-05	278	78	6	EFO_0010118
Disease	phosphatidylethanolamine measurement	PDXDC1 LIPC PLCG2 USH2A MUSK	9.77e-05	173	78	5	EFO_0010228
Disease	dihomo-linolenate 20:3n3 or n6 measurement	PDXDC1 MUSK	1.03e-04	6	78	2	EFO_0021046
Disease	1-palmitoyl-2-arachidonoyl-GPC (16:0/20:4n6) measurement	PDXDC1 MUSK	1.03e-04	6	78	2	EFO_0800390
Disease	1-oleoyl-2-docosahexaenoyl-GPE (18:1/22:6) measurement	LIPC MUSK	1.03e-04	6	78	2	EFO_0800471
Disease	1-stearoyl-2-dihomo-linolenoyl-GPC (18:0/20:3n3 or 6) measurement	PDXDC1 MUSK	1.03e-04	6	78	2	EFO_0800434
Disease	1-palmitoyl-2-dihomo-linolenoyl-GPE (16:0/20:3) measurement	LIPC MUSK	1.03e-04	6	78	2	EFO_0800444
Disease	1-dihomo-linolenoyl-GPE (20:3n3 or 6) measurement	PDXDC1 LIPC	1.03e-04	6	78	2	EFO_0800358
Disease	level of Phosphatidylcholine (18:2_20:3) in blood serum	LIPC MUSK	1.44e-04	7	78	2	OBA_2045108
Disease	1-oleoyl-2-arachidonoyl-GPE (18:1/20:4) measurement	LIPC MUSK	1.44e-04	7	78	2	EFO_0800470
Disease	1-oleoyl-2-linoleoyl-GPE (18:1/18:2) measurement	LIPC MUSK	1.44e-04	7	78	2	EFO_0800443
Disease	level of Phosphatidylcholine (17:0_18:2) in blood serum	LIPC MUSK	1.44e-04	7	78	2	OBA_2045086
Disease	cholesteryl ester 18:3 measurement	PDXDC1 LIPC MUSK	1.64e-04	40	78	3	EFO_0010346
Disease	2-arachidonoyl-GPE (20:4) measurement	LIPC MUSK	1.91e-04	8	78	2	EFO_0800260
Disease	Retinal Dystrophies	RPGR FUT5	1.91e-04	8	78	2	C0854723
Disease	fatty acid desaturase enzyme activity measurement	PDXDC1 MUSK	1.91e-04	8	78	2	EFO_0009791
Disease	phospholipid measurement, high density lipoprotein cholesterol measurement	PDXDC1 LIPC NYNRIN NCAN OBSL1 MUSK	2.10e-04	321	78	6	EFO_0004612, EFO_0004639
Disease	Ischemic stroke	PIK3C2G NYNRIN FURIN RNF17 CNTN6 EPG5	2.21e-04	324	78	6	HP_0002140
Disease	lipid measurement, high density lipoprotein cholesterol measurement	PDXDC1 LIPC NYNRIN NCAN OBSL1 MUSK	2.44e-04	330	78	6	EFO_0004529, EFO_0004612
Disease	1-arachidonoyl-GPE (20:4n6) measurement	LIPC MUSK	2.45e-04	9	78	2	EFO_0800248
Disease	level of Phosphatidylcholine (O-18:1_20:3) in blood serum	PDXDC1 MUSK	2.45e-04	9	78	2	OBA_2045130
Disease	1-palmitoyl-2-arachidonoyl-GPE (16:0/20:4) measurement	LIPC MUSK	2.45e-04	9	78	2	EFO_0800409
Disease	1-stearoyl-2-arachidonoyl-GPE (18:0/20:4) measurement	LIPC MUSK	2.45e-04	9	78	2	EFO_0800403
Disease	1-palmitoyl-2-linoleoyl-GPE (16:0/18:2) measurement	LIPC MUSK	2.45e-04	9	78	2	EFO_0800272
Disease	1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) measurement	PDXDC1 MUSK	2.45e-04	9	78	2	EFO_0800271
Disease	omega-3 polyunsaturated fatty acid measurement	PDXDC1 LIPC NCAN MUSK	2.76e-04	118	78	4	EFO_0010119
Disease	1-palmitoyl-2-oleoyl-GPE (16:0/18:1) measurement	LIPC MUSK	3.06e-04	10	78	2	EFO_0800608
Disease	linoleoyl-arachidonoyl-glycerol (18:2/20:4) [1] measurement	NCAN MUSK	3.06e-04	10	78	2	EFO_0800499
Disease	1-stearoyl-2-linoleoyl-GPE (18:0/18:2) measurement	LIPC MUSK	3.06e-04	10	78	2	EFO_0800402
Disease	cholesteryl ester 22:5 measurement	LIPC MUSK	3.06e-04	10	78	2	EFO_0021444
Disease	level of Phosphatidylcholine (16:0_20:3) in blood serum	PDXDC1 MUSK	3.06e-04	10	78	2	OBA_2045075
Disease	omega-6:omega-3 polyunsaturated fatty acid ratio	PDXDC1 LIPC MUSK	3.18e-04	50	78	3	EFO_0010732
Disease	triglyceride measurement, very low density lipoprotein cholesterol measurement	PDXDC1 LIPC LLGL2 NCAN MUSK	3.24e-04	224	78	5	EFO_0004530, EFO_0008317
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	PDXDC1 LIPC NYNRIN NCAN MUSK	3.24e-04	224	78	5	EFO_0004574, EFO_0008317
Disease	cholesteryl ester measurement, very low density lipoprotein cholesterol measurement	PDXDC1 LIPC NYNRIN NCAN MUSK	3.31e-04	225	78	5	EFO_0008317, EFO_0010351
Disease	loneliness measurement	NHLRC1 CNTN5 CNTN6 SLC5A4	3.33e-04	124	78	4	EFO_0007865
Disease	diglyceride measurement	PDXDC1 LIPC MUSK	3.38e-04	51	78	3	EFO_0010223
Disease	free cholesterol to total lipids in small HDL percentage	PDXDC1 LIPC MUSK	3.38e-04	51	78	3	EFO_0022285
Disease	docosahexaenoic acid measurement	PDXDC1 LIPC NCAN MUSK	3.65e-04	127	78	4	EFO_0007761
Disease	1-stearoyl-2-oleoyl-GPE (18:0/18:1) measurement	LIPC MUSK	3.74e-04	11	78	2	EFO_0800269
Disease	esterified cholesterol measurement	PDXDC1 LIPC NYNRIN MUSK	3.76e-04	128	78	4	EFO_0008589
Disease	very low density lipoprotein particle size measurement	PDXDC1 LIPC NCAN MUSK	4.35e-04	133	78	4	EFO_0008594
Disease	free cholesterol to total lipids in large HDL percentage	PDXDC1 LIPC MUSK	4.45e-04	56	78	3	EFO_0022279
Disease	linoleoyl-arachidonoyl-glycerol (18:2/20:4) [2] measurement	NCAN MUSK	4.48e-04	12	78	2	EFO_0800500
Disease	level of Phosphatidylinositol (16:0_18:1) in blood serum	PDXDC1 MUSK	4.48e-04	12	78	2	OBA_2045152
Disease	level of Phosphatidylcholine (O-16:0_20:3) in blood serum	PDXDC1 MUSK	4.48e-04	12	78	2	OBA_2045115
Disease	1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0) measurement	LIPC MUSK	4.48e-04	12	78	2	EFO_0800466
Disease	level of Phosphatidylcholine (16:0_20:2) in blood serum	LIPC MUSK	4.48e-04	12	78	2	OBA_2045074
Disease	microglial activation measurement	FAT3 KIF17 PCDH20	5.19e-04	59	78	3	EFO_0010940
Disease	phospholipid measurement	PDXDC1 LIPC NCAN MUSK	5.27e-04	140	78	4	EFO_0004639
Disease	phosphatidylcholine 40:7 measurement	PDXDC1 MUSK	5.28e-04	13	78	2	EFO_0021477
Disease	level of Phosphatidylcholine (16:0_18:3) in blood serum	LIPC MUSK	5.28e-04	13	78	2	OBA_2045072
Disease	level of Phosphatidylcholine (16:1_18:1) in blood serum	LIPC MUSK	5.28e-04	13	78	2	OBA_2045082
Disease	free cholesterol to total lipids in medium HDL percentage	PDXDC1 LIPC MUSK	5.46e-04	60	78	3	EFO_0022282
Disease	non-high density lipoprotein cholesterol measurement	SP1 LIPC CEL NYNRIN NCAN EPGN VN1R1 MUSK	5.91e-04	713	78	8	EFO_0005689
Disease	free cholesterol in very large HDL measurement	PDXDC1 LIPC MUSK	6.01e-04	62	78	3	EFO_0022273
Disease	1-stearoyl-2-dihomo-linolenoyl-GPI (18:0/20:3n3 or 6) measurement	PDXDC1 MUSK	6.15e-04	14	78	2	EFO_0022085
Disease	level of Phosphatidylcholine (18:1_18:2) in blood serum	LIPC MUSK	6.15e-04	14	78	2	OBA_2045100
Disease	level of Phosphatidylethanolamine (18:1_18:1) in blood serum	LIPC MUSK	6.15e-04	14	78	2	OBA_2045142
Disease	very low density lipoprotein cholesterol measurement	LIPC NYNRIN CNTN5 NCAN MUSK	6.39e-04	260	78	5	EFO_0008317
Disease	level of Phosphatidylcholine (O-18:1_20:4) in blood serum	LIPC MUSK	7.08e-04	15	78	2	OBA_2045131
Disease	level of Phosphatidylcholine (16:0_16:0) in blood serum	LIPC MUSK	7.08e-04	15	78	2	OBA_2045067
Disease	total lipids in very large HDL measurement	PDXDC1 LIPC MUSK	7.21e-04	66	78	3	EFO_0022312
Disease	phospholipids in very large HDL measurement	PDXDC1 LIPC MUSK	7.21e-04	66	78	3	EFO_0022298
Disease	level of triacylglycerol (56:6) in blood serum	NCAN MUSK	8.08e-04	16	78	2	OBA_2020007
Disease	level of Phosphatidylcholine (18:0_18:2) in blood serum	LIPC MUSK	8.08e-04	16	78	2	OBA_2045090
Disease	level of Phosphatidylcholine (18:0_20:3) in blood serum	PDXDC1 MUSK	8.08e-04	16	78	2	OBA_2045093
Disease	cholesterol in very large HDL measurement	PDXDC1 LIPC MUSK	8.21e-04	69	78	3	EFO_0022229
Disease	temporal horn of lateral ventricle volume measurement	NHLRC1 DIP2C EPGN	9.29e-04	72	78	3	EFO_0010333
Disease	phospholipids in large HDL measurement	PDXDC1 LIPC MUSK	9.67e-04	73	78	3	EFO_0022190
Disease	esterified cholesterol measurement, high density lipoprotein cholesterol measurement	LIPC OBSL1	1.15e-03	19	78	2	EFO_0004612, EFO_0008589
Disease	level of Phosphatidylethanolamine (18:0_20:4) in blood serum	LIPC MUSK	1.15e-03	19	78	2	OBA_2045140
Disease	level of Sphingomyelin (d38:2) in blood serum	LIPC MUSK	1.15e-03	19	78	2	OBA_2045179
Disease	diacylglycerol 38:5 measurement	LIPC MUSK	1.15e-03	19	78	2	EFO_0020067
Disease	monounsaturated fatty acids; 16:1, 18:1 measurement	PDXDC1 LIPC MUSK	1.17e-03	78	78	3	EFO_0022187
Disease	free cholesterol in large HDL measurement	PDXDC1 LIPC MUSK	1.22e-03	79	78	3	EFO_0022157
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	NHLRC1 KLHL29 XYLT1 FURIN SORCS3 FIGN GRM8 USH2A	1.25e-03	801	78	8	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	hypertension	KLHL29 STXBP5 FURIN FIGN KIAA2013	1.34e-03	307	78	5	EFO_0000537
Disease	sensory perception of sweet taste	XYLT1 CNTN5 DIP2C	1.35e-03	82	78	3	GO_0050916
Disease	docosahexaenoic acid to total fatty acids percentage	PDXDC1 LIPC	1.40e-03	21	78	2	EFO_0022262
Disease	level of Phosphatidylcholine (16:1_18:2) in blood serum	LIPC MUSK	1.40e-03	21	78	2	OBA_2045083
Disease	cholesteryl ester measurement, high density lipoprotein cholesterol measurement	PDXDC1 LIPC NYNRIN NCAN MUSK	1.44e-03	312	78	5	EFO_0004612, EFO_0010351
Disease	free cholesterol measurement, high density lipoprotein cholesterol measurement	PDXDC1 LIPC NYNRIN OBSL1 MUSK	1.50e-03	315	78	5	EFO_0004612, EFO_0008591
Disease	total cholesterol measurement, high density lipoprotein cholesterol measurement	PDXDC1 LIPC NYNRIN NCAN MUSK	1.50e-03	315	78	5	EFO_0004574, EFO_0004612
Disease	lipoprotein measurement, phospholipid measurement	LIPC NYNRIN NCAN	1.50e-03	85	78	3	EFO_0004639, EFO_0004732
Disease	free cholesterol:total lipids ratio, intermediate density lipoprotein measurement	PDXDC1 LIPC MUSK	1.55e-03	86	78	3	EFO_0008595, EFO_0020945
Disease	chronic widespread pain	PLCG2 LARP4	1.68e-03	23	78	2	EFO_0010099
Disease	phosphatidylserines measurement	LIPC MUSK	1.68e-03	23	78	2	EFO_0020049
Disease	venous thromboembolism, tissue plasminogen activator measurement	STXBP5 PLCG2	1.68e-03	23	78	2	EFO_0004286, EFO_0004791
Disease	lipid measurement, lipoprotein measurement	LIPC NYNRIN NCAN	1.77e-03	90	78	3	EFO_0004529, EFO_0004732
Disease	level of Phosphatidylethanolamine (16:0_18:2) in blood serum	LIPC MUSK	1.83e-03	24	78	2	OBA_2045136
Disease	childhood trauma measurement	FURIN SORCS3	1.83e-03	24	78	2	EFO_0007979
Disease	omega-6 polyunsaturated fatty acid measurement	PDXDC1 LIPC NCAN MUSK	1.87e-03	197	78	4	EFO_0005680

Protein segments in the cluster

Peptide	Gene	Start	Entry
VPVGGVVKSVAWNPS	BOP1	451	Q14137
QNSGWGPILVSLQVP	EPG5	2341	Q9HCE0
TVTPPITAQQGNWTV	EPGN	26	Q6UW88
VQNWLVEVPTVSPIS	ERVK-19	176	O71037
VQNWLVEVPTVSPIS	ERVK-8	176	Q902F8
ASPCAQVEVPWPVVV	ALDH16A1	391	Q8IZ83
NIPEPVVIGIVWSSV	BZW1	286	Q7L1Q6
AISQSGVALSPWVIQ	CEL	236	P19835
PITVIWGVSPEDNGN	DISP1	786	Q96F81
QGSQVSLGWEPVIPL	CNTN5	986	O94779
AVTPQQTWASPAEVV	C18orf25	376	Q96B23
PEWPALSGLVAQAQA	ANKRD33	261	Q7Z3H0
FTCVAIGVPTPIINW	HSPG2	426	P98160
GVWDVSQPSPVTLQI	PIK3C2G	611	O75747
PVQTVGQWLESIGLP	ANKS1B	811	Q7Z6G8
TWLRNGAVVTPGPQV	OBSL1	1391	O75147
VTLPQAGPWNTASLV	DAB2	506	P98082
VSQISVWVPENAPVN	PCDH20	211	Q8N6Y1
LVTNEIITQGPPVDW	FIGN	471	Q5HY92
IITQGPPVDWNDIAG	FIGN	476	Q5HY92
PVPGQLGNVVSSVWP	FOXB2	301	Q5VYV0
LLAQPAAGQATIPEW	MDN1	4026	Q9NU22
GEQVLWGPITQIFPT	MAGEA11	86	P43364
PSPGALWLQVAVTGV	MAVS	511	Q7Z434
LVVIDLQTAGWPPVQ	LLGL2	361	Q6P1M3
EPTAIQAQGWPVALS	DDX5	116	P17844
GIAPIWISGENIPQE	PDCD2	261	Q16342
SVPVWSGVNIAGVPL	LDHAL6B	246	Q9BYZ2
IPVVGSVLNWFSPVQ	PDXDC1	641	Q6P996
PAQPVNVGLVDWITL	LIPC	111	P11150
QGLPFAQWDGPTVVV	PPFIA1	871	Q13136
ATVTIPIWQNKPHGA	MTFR1L	6	Q9H019
EELPSANGSVPIVWQ	PGAP4	81	Q9BRR3
ANGSVPIVWQATPRP	PGAP4	86	Q9BRR3
TTVVNDNGLSPIWAP	PLCG2	1101	P16885
SPWAVVPVFVAILGI	GRM8	581	O00222
VQNWLVEVPTVSPIS	ERVK-7	936	P63135
TNQGLPVTPTFWRVV	MYBBP1A	381	Q9BQG0
PDASISWVIPGNNVL	IGSF10	601	Q6WRI0
VPVSVTWRFQPVGTV	IGSF3	576	O75054
QWEIPVCIQVIPVAG	ICE2	301	Q659A1
VTVWQPAFPVQTTTA	GFRA1	351	P56159
VQNWLVEVPIVSPIS	ERVK-25	176	P61570
TNTWAVRIPGGPAVA	FURIN	31	P09958
VGVVSVQPANTPLWF	FAT3	1381	Q8TDW7
WLVIDPVPAAVPTQV	CC2D1A	806	Q6P1N0
GVVTNWPPSLEAALQ	DIP2C	311	Q9Y2E4
RTPFSVGWQAVATVP	CNTN6	636	Q9UQ52
VWQEIAPGNTDATPV	LARP4	21	Q71RC2
VLQNVPTSAVWVAGP	KIAA1210	286	Q9ULL0
AADWTVQIVVNPPGG	LAMB4	631	A4D0S4
VQNWLVEVPTVSPIS	HERVK_113	176	Q902F9
ALGVPITPVNAWVSA	FAM186A	1646	A6NE01
EILAPSVNVDPVVWN	SALL4	956	Q9UJQ4
SVVEWVTPLGVPVIQ	POLRMT	1066	O00411
TADLPIVWGNPQITV	CFAP47	2446	Q6ZTR5
IESAGQTWQQVPPVR	PPHLN1	341	Q8NEY8
VAWAQIPEETGLPQG	CAMSAP2	736	Q08AD1
SLPWGVETTPQNGIV	NHLRC1	216	Q6VVB1
TAPWSNLQIEVVGPV	NYNRIN	1611	Q9P2P1
PGVWLEAQAPVALVA	KIF17	691	Q9P2E2
WVGLPPNIEAAAVSL	MMP28	366	Q9H239
CVPQQVTIGKPVSWI	RPGR	181	Q92834
WVPVTLVAAGAAQPA	HSFX1	366	Q9UBD0
NALEAWAVPVVLGPS	FUT5	276	Q11128
ADWSEGVQVPSVPIQ	RPSA	246	P08865
LQVVWSTPARNNAPG	USH2A	2451	O75445
VRVIWTSPSNPNGVV	USH2A	3036	O75445
TRIQVFWIAPPAGTG	SPON1	141	Q9HCB6
VSGWVNAPPAAVPAN	TNRC6C	506	Q9HCJ0
VNISAVVWPSQLGTL	SORCS3	931	Q9UPU3
PWPSVNRNVAVGFVP	NCAN	726	O14594
VSWTPPENQNIVVRG	NEO1	756	Q92859
VSIVWVPLVQVSQNG	SLC5A4	436	Q9NY91
IRTPTVGPNGQVSWQ	SP1	451	P08047
LVWVGGEPPQQITSL	STXBP5	621	Q5T5C0
LSQSPGAVPQALVAW	ROBO4	681	Q8WZ75
TTPVGNVWQPDAIEV	RNF17	1296	Q9BXT8
PNVTVTVIWVDPVNV	XYLT1	776	Q86Y38
VQNWLVEVPTVSPIS	ERVK-10	936	P10266
NPGQWIVTNSVLVAS	VN1R1	301	Q9GZP7
PGANVIIPEGTWIVA	PKHD1L1	3051	Q86WI1
AVGVQWPRGPVSQNS	PRAG1	496	Q86YV5
ISIAWVPIVQSAQSG	SLC5A1	436	P13866
QWQTAVIIGPDGQPL	ZNF711	366	Q9Y462
EPGQPVTVICVFNWA	SIGLEC16	156	A6NMB1
PWVTTVAAGNQPTLI	KLHL29	146	Q96CT2
LWVVHVSGPINPQVL	KIAA2013	286	Q8IYS2
TGIPVPTITWIENGN	MUSK	236	O15146